Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): protocol and statistical analysis plan for a randomized controlled trial

Haleema Shakur, Bukola Fawole, Modupe Kuti, Oladapo Olayemi, Adenike Bello, Olayinka Ogunbode, Taiwo Kotila, Chris O Aimakhu, Sumaya Huque, Meghann Gregg, Ian Roberts, Haleema Shakur, Bukola Fawole, Modupe Kuti, Oladapo Olayemi, Adenike Bello, Olayinka Ogunbode, Taiwo Kotila, Chris O Aimakhu, Sumaya Huque, Meghann Gregg, Ian Roberts

Abstract

Background: Postpartum haemorrhage (PPH) is a leading cause of maternal death. Tranexamic acid has the potential to reduce bleeding and a large randomized controlled trial of its effect on maternal health outcomes in women with PPH (The WOMAN trial) is ongoing. We will examine the effect of tranexamic acid on fibrinolysis and coagulation in a subset of WOMAN trial participants. Methods. Adult women with clinically diagnosed primary PPH after vaginal or caesarean delivery are eligible for inclusion in the WOMAN trial. In a sub-group of trial participants, blood samples will be collected at baseline and 30 minutes after the first dose of tranexamic acid or matching placebo. Our primary objective is to evaluate the effect of tranexamic acid on fibrinolysis. Fibrinolysis will be assessed by measuring D-dimers and by rotational thromboelastometry (ROTEM). Secondary outcomes are international normalized ratio (INR), prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen, haemoglobin and platelets. We aim to include about 180 women from the University College Hospital, Ibadan in Nigeria. Discussion: This sub-study of WOMAN trial participants should provide information on the mechanism of action of tranexamic acid in women with postpartum haemorrhage. We present the trial protocol and statistical analysis plan. The trial protocol was registered prior to the start of patient recruitment. The statistical analysis plan was completed before un-blinding. Trial registration: The trial was registered: ClinicalTrials.gov, Identifier NCT00872469 https://ichgcp.net/clinical-trials-registry/NCT00872469; ISRCTN registry, Identifier ISRCTN76912190 http://www.isrctn.com/ISRCTN76912190 (Registration date: 22/03/2012).

Keywords: D-dimer; Fibrinogen; Postpartum Haemorrhage; ROTEM; Tranexamic Acid.

Conflict of interest statement

Competing interests: No competing interests were disclosed.

Figures

Figure 1.. Study overview.
Figure 1.. Study overview.
Figure 2.. Trial profile.
Figure 2.. Trial profile.

References

    1. Carroli G, Cuesta C, Abalos E, et al. : Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol. 2008;22(6):999–1012. 10.1016/j.bpobgyn.2008.08.004
    1. Ronsmans C, Graham WJ, Lancet Maternal Survival Series steering group : Maternal mortality: who, when, where, and why. Lancet. 2006;368(9542):1189–200. 10.1016/S0140-6736(06)69380-X
    1. Geneva: World Health Organization: WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage. World Health Organization.2012.
    1. Cesarman-Maus G, Hajjar KA: Molecular mechanisms of fibrinolysis. Br J Haematol. 2005;129(3):307–321. 10.1111/j.1365-2141.2005.05444.x
    1. Ker K, Edwards P, Perel P, et al. : Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054. 10.1136/bmj.e3054
    1. Ker K, Prieto-Merino D, Roberts I: Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. Br J Surg. 2013;100(10):1271–9. 10.1002/bjs.9193
    1. CRASH-2 collaborators, . Roberts I, Shakur H, et al. : The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011;377(9771):1096–1101, 1101.e1–2. 10.1016/S0140-6736(11)60278-X
    1. Sawamura A, Hayakawa M, Gando S, et al. : Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb Res. 2009;124(5):608–613. 10.1016/j.thromres.2009.06.034
    1. Gall L, Davenport R, Brohi K: Effect of early tranexamic acid on the coagulation system in patients with suspected traumatic haemorrhage: a prospective cohort study. Lancet. 2016; [accessed August 10 2016].
    1. Kruithof EK, Tran-Thang C, Gudinchet A, et al. : Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood. 1987;69(2):460–6.
    1. Ducloy-Bouthors AS, Duhamel A, Kipnis E, et al. : Postpartum haemorrhage related early increase in D-dimers is inhibited by tranexamic acid: haemostasis parameters of a randomized controlled open labelled trial. Br J Anaesth. 2016;116(5):641–648. 10.1093/bja/aew021
    1. Shakur H, Elbourne D, Gülmezoglu M, et al. : The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials. 2010;11:40. 10.1186/1745-6215-11-40
    1. The WOMAN Trial Protocol. [cited 2016 05/08/2016].
    1. Olson JD: D-dimer: An Overview of Hemostasis and Fibrinolysis, Assays, and Clinical Applications. Adv Clin Chem.Elsevier,2015;69:1–46. 10.1016/bs.acc.2014.12.001
    1. Levrat A, Gros A, Rugeri L, et al. : Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth. 2008;100(6):792–797. 10.1093/bja/aen083
    1. Hagemo JS, Christiaans SC, Stanworth SJ, et al. : Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study. Crit Care. 2015;19(1):97. 10.1186/s13054-015-0823-y
    1. Epiney M, Boehlen F, Boulvain M, et al. : D-dimer levels during delivery and the postpartum. J Thromb Haemost. 2005;3(2):268–71. 10.1111/j.1538-7836.2004.01108.x
    1. Worldwide prevalence of anaemia 1993–2005 WHO Global Database on Anaemia.
    1. Prevention And Management Of Postpartum Haemorrhage. [accessed 10 August 2016].
    1. James AH, Jamison MG, Brancazio LR, et al. : Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006;194(5):1311–1315. 10.1016/j.ajog.2005.11.008
    1. International Conference on Harmonisation: E6(R1): Good clinical practice. Retrieved 2 December, 2016.1996.
    1. Ducloy-Bouthors AS, Duhamel A, Kipnis E, Tournoys A, Prado-Dupont A, Elkalioubie A, Jeanpierre E, Debize G, Peynaud-Debayle E, DeProst D, Huissoud C, Rauch A, Susen S: Postpartum haemorrhage related early increase in D-dimers is inhibited by tranexamic acid: haemostasis parameters of a randomized controlled open labelled trial. Br J Anaesth.2016;116(5) : 10.1093/bja/aew021 641-8 10.1093/bja/aew021
    1. Faraoni D, Van der Linden P, Ducloy-Bouthors AS, Goobie SM, DiNardo JA, Nielsen VG: Quantification of Fibrinolysis Using Velocity Curves Measured with Thromboelastometry in Children with Congenital Heart Disease. Anesth Analg.2015;121(2) : 10.1213/ANE.0000000000000795 486-91 10.1213/ANE.0000000000000795
    1. Huissoud C, Carrabin N, Audibert F, Levrat A, Massignon D, Berland M, Rudigoz RC: Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG.2009;116(8) : 10.1111/j.1471-0528.2009.02187.x 1097-102 10.1111/j.1471-0528.2009.02187.x
    1. Collins PW, Lilley G, Bruynseels D, Laurent DB, Cannings-John R, Precious E, Hamlyn V, Sanders J, Alikhan R, Rayment R, Rees A, Kaye A, Hall JE, Paranjothy S, Weeks A, Collis RE: Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood.2014;124(11) : 10.1182/blood-2014-04-567891 1727-36 10.1182/blood-2014-04-567891
    1. Goswami U, Sarangi S, Gupta S, Babbar S: Comparative evaluation of two doses of tranexamic acid used prophylactically in anemic parturients for lower segment cesarean section: A double-blind randomized case control prospective trial. Saudi J Anaesth.2013;7(4) : 10.4103/1658-354X.121077 427-31 10.4103/1658-354X.121077
    1. Ducloy-Bouthor A.S., Jeanpierre E, Hennart B, Baptiste A.S., Giovannoni S, Saidi I, Simon E, Lannoy D, Allorge D, Duhamel A, Susen S: Thrombin and plasmin generation as measured by a single well technique during haemorrhagic and non-hemorrhagic caesarean section: pilot study. Thrombosis Research.2017;151(1) : 10.1016/S0049-3848(17)30110-X S113 10.1016/S0049-3848(17)30110-X
    1. Ducloy-Bouthors A.S., Jeanpierre E, Hennart B, Giovannoni S, Saidi I, Simon E, Lannoy D, Allorge D, Duhamel A, Susen S: TRAnexamic acid to reduce blood loss in hemorrhagic CESarean delivery: therapeutic and pharmaco-biological dose-ranging multicenter randomized double blind placebo controlled study: TRACES trial methodology. Thrombosis Research.2017;151(1) : 10.1016/S0049-3848(17)30109-3 S113 10.1016/S0049-3848(17)30109-3
    1. Jonard M, Ducloy-Bouthors AS, Fourrier F: Comparison of Two Diagnostic Scores of Disseminated Intravascular Coagulation in Pregnant Women Admitted to the ICU. PLoS One.2016;11(11) : 10.1371/journal.pone.0166471 e0166471 10.1371/journal.pone.0166471

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다